2 recruiting. 2 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 2 | Recruiting 2 |
Follow Sofosbuvir: new trials by email Literature Review of Sofosbuvir trials Research Report on Sofosbuvir
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Implementing Low-Barrier HCV Treatment in a Jail Setting Sofosbuvir / Velpatasvir Oral Tablet [Epclusa], Community Health Worker - HEPATITIS C (HCV), Incarceration | Phase 4 | Recruiting | Lifespan | 40 | 2025-06-11 | 2026-02-27 |
| Strategic Treatment Reduction in Very Early Liver Disease With 4 Weeks Sofosbuvir Plus Glecepravir-pibrentasvir Sofosbuvir 400mg [Sovaldi], Glecaprevir/pibrentasvir (300mg/120mg) - Hepatitis C | Phase 4 | Recruiting | Kirby Institute | 30 | 2020-02-11 | 2026-07-29 |
Hepatitis C (2)
Kirby Institute (1) · Lifespan (1)
Australia (1) · United States (1)
Marianne Martinello, MD, PhD (1)
R34DA061732 (1)